Immunomedics

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences. Wikipedia

• Industry:  Biotechnology
• Founder:  David M. Goldenberg
• Defunct:  October 23, 2020
• Parent:  Gilead Sciences
• Data source:  DuckDuckGo